109 related articles for article (PubMed ID: 3243921)
1. Rapid estimation of unbound lidocaine clearance in cardiac patients: implications for reducing toxicity.
Denson DD; Toltzis RJ; Ernst TF; Youngs CH; Thomas RL; Grummich KW
J Clin Pharmacol; 1988 Nov; 28(11):995-1000. PubMed ID: 3243921
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
Sawyer DR; Ludden TM; Crawford MH
Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
[TBL] [Abstract][Full Text] [Related]
3. Hemodialysis clearance of total and unbound lidocaine.
Jacobi J; McGory RW; McCoy H; Matzke GR
Clin Pharm; 1983; 2(1):54-7. PubMed ID: 6883930
[TBL] [Abstract][Full Text] [Related]
4. Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias.
Thomson AH; Kelman AW; de Vane PJ; Hillis WS; Whiting B
Ther Drug Monit; 1987 Sep; 9(3):283-91. PubMed ID: 3672571
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effectiveness of lidocaine in patients with ventricular arrhythmias estimated relative to measurements of drug concentration in serum].
Sinkiewicz W; Marzec A; Hoffman A; Jankowski A; Bartuzi Z; Romański B
Kardiol Pol; 1989; 32(7-9):366-71. PubMed ID: 2639975
[TBL] [Abstract][Full Text] [Related]
6. Steady-state pharmacokinetics and bioavailability of total and unbound disopyramide in children with cardiac arrhythmias.
Chiba K; Koike K; Nakamoto M; Echizen H; Ishizawa A; Ishizaki T
Ther Drug Monit; 1992 Apr; 14(2):112-8. PubMed ID: 1585394
[TBL] [Abstract][Full Text] [Related]
7. Disposition of total and unbound etoposide following high-dose therapy.
Schwinghammer TL; Fleming RA; Rosenfeld CS; Przepiorka D; Shadduck RK; Bloom EJ; Stewart CF
Cancer Chemother Pharmacol; 1993; 32(4):273-8. PubMed ID: 8324869
[TBL] [Abstract][Full Text] [Related]
8. The effect of oral cimetidine on total and unbound serum lidocaine concentrations in patients with suspected myocardial infarction.
Berk SI; Gal P; Bauman JL; Douglas JB; McCue JD; Powell JR
Int J Cardiol; 1987 Jan; 14(1):91-4. PubMed ID: 3804509
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Nattel S; Gagne G; Pineau M
Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
Fredrick DS; Boersma RB
Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
[TBL] [Abstract][Full Text] [Related]
11. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.
Pfeifer HJ; Greenblatt DJ; Koch-Weser J
Am Heart J; 1976 Aug; 92(2):168-73. PubMed ID: 941829
[TBL] [Abstract][Full Text] [Related]
12. Free and total lidocaine levels in cardiac surgical patients.
Landow L; Wilson J; Heard SO; Townsend P; VanderSalm TJ; Okike ON; Pezzella TA; Pasque M
J Cardiothorac Anesth; 1990 Jun; 4(3):340-7. PubMed ID: 1983405
[TBL] [Abstract][Full Text] [Related]
13. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Bax ND; Tucker GT; Woods HF
Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction.
Wyse DG; Kellen J; Rademaker AW
J Am Coll Cardiol; 1988 Aug; 12(2):507-13. PubMed ID: 3292630
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
Drayer DE; Lorenzo B; Werns S; Reidenberg MM
Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
[TBL] [Abstract][Full Text] [Related]
18. Impairment of lidocaine clearance in elderly male subjects.
Abernethy DR; Greenblatt DJ
J Cardiovasc Pharmacol; 1983; 5(6):1093-6. PubMed ID: 6196560
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of lidocaine after intramuscular injection in patients with acute myocardial infarction (author's transl)].
Oltmanns D; Siegers CP
Z Kardiol; 1979 Mar; 68(3):131-6. PubMed ID: 442753
[TBL] [Abstract][Full Text] [Related]
20. Rapid assessment of lidocaine in cardiac patients by enzyme immunoassay.
Miller E; Walberg C; Haywood LJ
Ther Drug Monit; 1981; 3(1):85-9. PubMed ID: 7015581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
